India Plans to Boost Domestic Value Addition in Medical Devices Sector Under PLI Scheme
The Indian government aims to increase domestic value addition in the medical devices sector, focusing on component manufacturing over simple assembly. Department of Pharmaceuticals Secretary Manoj Joshi highlighted plans to incentivize companies to raise local value addition to 40-45%, especially under the next production linked incentive (PLI) scheme. The government is also considering extending eligibility for companies that invested in the first PLI round but have yet to claim incentives. Industry experts emphasize shifting focus from volume to higher-value, higher-risk medical devices.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 42/100.
Outlets measured: thefinancialexpress, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 21 Aug, 09:21 am. Other outlets followed.